Philip R. Dormitzer
About
In The Last Decade
Philip R. Dormitzer
78 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Infectious Diseases 3.7k
- Epidemiology 2.1k
- Molecular Biology 1.7k
- Animal Science and Zoology 1.2k
- Cardiology and Cardiovascular Medicine 972
Countries citing papers authored by Philip R. Dormitzer
This map shows the geographic impact of Philip R. Dormitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip R. Dormitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip R. Dormitzer more than expected).
Fields of papers citing papers by Philip R. Dormitzer
This network shows the impact of papers produced by Philip R. Dormitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip R. Dormitzer. The network helps show where Philip R. Dormitzer may publish in the future.
Co-authorship network of co-authors of Philip R. Dormitzer
This figure shows the co-authorship network connecting the top 25 collaborators of Philip R. Dormitzer. A scholar is included among the top collaborators of Philip R. Dormitzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip R. Dormitzer. Philip R. Dormitzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 31 | |
| 5 | Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera breakdown → | 383 |
| 6 | BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants breakdown → | 212 |
| 7 | 29 | |
| 8 | 62 | |
| 9 | Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera breakdown → | 333 |
| 10 | 4 | |
| 11 | 37 | |
| 12 | 211 | |
| 13 | 1 | |
| 14 | 117 | |
| 15 | 207 | |
| 16 | 0 | |
| 17 | 288 | |
| 18 | 289 | |
| 19 | 177 | |
| 20 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.